IXICO (LON:IXI) Shares Pass Below 200-Day Moving Average – Should You Sell?

Shares of IXICO plc (LON:IXIGet Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 10.52 ($0.14) and traded as low as GBX 9.63 ($0.12). IXICO shares last traded at GBX 9.63 ($0.12), with a volume of 58,368 shares.

IXICO Trading Down 2.2 %

The company has a current ratio of 2.85, a quick ratio of 4.90 and a debt-to-equity ratio of 3.32. The company has a market cap of £8.84 million, a PE ratio of -2.47, a P/E/G ratio of -0.38 and a beta of 0.86. The business’s 50-day simple moving average is GBX 11.52 and its 200-day simple moving average is GBX 10.52.

IXICO (LON:IXIGet Free Report) last released its quarterly earnings results on Wednesday, December 4th. The company reported GBX (4.14) (($0.05)) earnings per share for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. As a group, analysts expect that IXICO plc will post -289.3584879 EPS for the current fiscal year.

About IXICO

(Get Free Report)

IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease.

Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.

Further Reading

Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.